Surrogacy of Time to Progression for Overall Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Time to progression (TTP) is widely used as the endpoint in early-phase trials of advanced hepatocellular carcinoma (HCC). However, the relevance of using TTP as a surrogate marker for overall survival (OS) in pivotal trials remains uncertain. The PubMed database and ASCO Meeting Library were search...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Liver Cancer
Главные авторы: Terashima, Takeshi, Yamashita, Tatsuya, Toyama, Tadashi, Arai, Kuniaki, Kawaguchi, Kazunori, Kitamura, Kazuya, Yamashita, Taro, Sakai, Yoshio, Mizukoshi, Eishiro, Honda, Masao, Kaneko, Shuichi
Формат: Artigo
Язык:Inglês
Опубликовано: S. Karger AG 2019
Предметы:
Original Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6465721/
https://ncbi.nlm.nih.gov/pubmed/31019903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000489505
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы